AbbVie | ABBV - الدين





الدين تغيير تاريخ
AbbVie USD 70.82B 2.04B 2026-06
Abbott USD 34.05B 20.19B 2026-03
ALKERMES USD 1.57B 10.58M 2026-09
Amgen USD 57.3B 19M 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
J&J USD 49.04B 5.95B 2026-06
Medtronic USD 28.15B 192M 2026-06
Merck USD 53.91B 4.79B 2026-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.29B 337.7M 2026-06
Pfizer USD 62.67B 523M 2026-09
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
UCB EUR 3.03B 12M 2024-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09
Zoetis USD 9.24B 0 2026-06